Associations Between Weight and Lower Respiratory Tract Disease Outcomes in Hospitalized Children.


Journal

Hospital pediatrics
ISSN: 2154-1671
Titre abrégé: Hosp Pediatr
Pays: United States
ID NLM: 101585349

Informations de publication

Date de publication:
01 08 2022
Historique:
pubmed: 14 7 2022
medline: 3 8 2022
entrez: 13 7 2022
Statut: ppublish

Résumé

To identify associations between weight status and clinical outcomes in children with lower respiratory tract infection (LRTI) or asthma requiring hospitalization. We performed a retrospective cohort study of 2 to 17 year old children hospitalized for LRTI and/or asthma from 2009 to 2019 using electronic health record data from the PEDSnet clinical research network. Children <2 years, those with medical complexity, and those without a calculable BMI were excluded. Children were classified as having underweight, normal weight, overweight, or class 1, 2, or 3 obesity based on Body Mass Index percentile for age and sex. Primary outcomes were need for positive pressure respiratory support and ICU admission. Subgroup analyses were performed for children with a primary diagnosis of asthma. Outcomes were modeled with mixed-effects multivariable logistic regression incorporating age, sex, and payer as fixed effects. We identified 65 132 hospitalizations; 6.7% with underweight, 57.8% normal weight, 14.6% overweight, 13.2% class 1 obesity, 5.0% class 2 obesity, and 2.8% class 3 obesity. Overweight and obesity were associated with positive pressure respiratory support (class 3 obesity versus normal weight odds ratio [OR] 1.62 [1.38-1.89]) and ICU admission (class 3 obesity versus normal weight OR 1.26 [1.12-1.42]), with significant associations for all categories of overweight and obesity. Underweight was also associated with positive pressure respiratory support (OR 1.39 [1.24-1.56]) and ICU admission (1.40 [1.30-1.52]). Both underweight and overweight or obesity are associated with increased severity of LRTI or asthma in hospitalized children.

Identifiants

pubmed: 35822402
pii: 188516
doi: 10.1542/hpeds.2021-006404
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

734-743

Informations de copyright

Copyright © 2022 by the American Academy of Pediatrics.

Auteurs

Elizabeth E Halvorson (EE)

Departments of Pediatrics.

Amit Saha (A)

Anesthesiology.

Christopher B Forrest (CB)

Applied Clinical Research Center, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.

Hanieh Razzaghi (H)

Applied Clinical Research Center, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.

Mark Brittan (M)

Department of Pediatrics, University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, Colorado.

Dimitri A Christakis (DA)

Department of Pediatrics, University of Washington and Seattle Children's Hospital, Seattle, Washington.

F Sessions Cole (FS)

Edward Mallinckrodt Department of Pediatrics, Washington University School of Medicine and St. Louis Children's Hospital, St. Louis, Missouri.

Asuncion Mejias (A)

Division of Infectious Diseases, Department of Pediatrics, Nationwide Children's Hospital and The Ohio State University, Columbus, Ohio.

Thao-Ly Tam Phan (TT)

Department of Pediatrics, Nemours Children's Health System, Wilmington, Delaware.

Michael C McCrory (MC)

Anesthesiology.

Brian J Wells (BJ)

Family Medicine.

Joseph A Skelton (JA)

Departments of Pediatrics.
Epidemiology and Prevention, Wake Forest University School of Medicine, Winston-Salem, North Carolina.

Katherine A Poehling (KA)

Departments of Pediatrics.
Epidemiology and Prevention, Wake Forest University School of Medicine, Winston-Salem, North Carolina.

Joel S Tieder (JS)

Department of Pediatrics, University of Washington and Seattle Children's Hospital, Seattle, Washington.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH